we are hiring!

Felix Neuhäusel

Felix joined the group in July 2021 to carry out his Master's thesis in the fields of functional genomics. He is studying Pharmaceutical Biotechnology at the University of Applied Sciences Fresenius and has worked in aseptic drug manufacturing at Sanofi prior to his joining. His thesis is focusing on a combinatorial CRISPR activation/CRISPR knockout screening approach to identify synthetic lethalities in common cancers. 

Felix Neuhäusel
  • Gene Editing